Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Evaluation of Ketoconazole and Its Alternative Clinical CYP3A4/5 Inhibitors as Inhibitors of Drug Transporters: The In Vitro Effects of Ketoconazole, Ritonavir, Clarithromycin, and Itraconazole on 13 Clinically-Relevant Drug Transporters

Lydia M. M. Vermeer, Caleb D. Isringhausen, Brian W. Ogilvie and David B. Buckley
Drug Metabolism and Disposition March 2016, 44 (3) 453-459; DOI: https://doi.org/10.1124/dmd.115.067744
Lydia M. M. Vermeer
Sekisui XenoTech, LLC Kansas City, Kansas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caleb D. Isringhausen
Sekisui XenoTech, LLC Kansas City, Kansas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian W. Ogilvie
Sekisui XenoTech, LLC Kansas City, Kansas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brian W. Ogilvie
David B. Buckley
Sekisui XenoTech, LLC Kansas City, Kansas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 44 no. 3 453-459
DOI 
https://doi.org/10.1124/dmd.115.067744
PubMed 
26668209

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received October 8, 2015
  • Accepted December 11, 2015
  • Published online February 16, 2016.

Article Versions

  • Earlier version (December 14, 2015 - 08:02).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Lydia M. M. Vermeer1,
  2. Caleb D. Isringhausen1,
  3. Brian W. Ogilvie, and
  4. David B. Buckley
  1. Sekisui XenoTech, LLC Kansas City, Kansas
  1. Address correspondence to:
    Dr. David B. Buckley, Sekisui XenoTech, LLC, 1101 West Cambridge Circle Drive, Kansas City, KS 66103. E-mail: dbuckley{at}xenotechllc.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 2017114229
Sep 2017113341
Oct 2017186643
Nov 2017115756
Dec 201735459
Jan 2018134037
Feb 2018105247
Mar 2018115759
Apr 201884659
May 201853141
Jun 201875247
Jul 201846250
Aug 2018104349
Sep 201824047
Oct 201855649
Nov 2018115261
Dec 2018145678
Jan 2019235098
Feb 2019164484
Mar 2019175891
Apr 2019235276
May 2019174669
Jun 2019135099
Jul 20191244104
Aug 2019115276
Oct 2019197688
Nov 2019165153
Dec 2019167057
Jan 2020117070
Feb 2020167285
Mar 2020118979
May 2020127058
Jun 2020116865
Jul 2020145549
Aug 202087554
Sep 20202310982
Oct 2020179160
Nov 2020118262
Dec 2020137048
Jan 2021198377
Feb 2021169354
Mar 202174946
Apr 2021144130
May 2021194542
Jun 2021113536
Jul 2021114952
Aug 2021127556
Sep 202187990
Oct 2021117381
Nov 2021118679
Dec 2021149272
Jan 2022911365
Feb 2022464238
Mar 20222072648
Apr 202292929
May 2022972135
Jun 2022952429
Jul 2022891939
Aug 2022852019
Sep 202287821
Oct 20221141820
Nov 20222141124
Dec 20221101520
Jan 20231511730
Feb 2023751334
Mar 20231451931

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 44 (3)
Drug Metabolism and Disposition
Vol. 44, Issue 3
1 Mar 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of Ketoconazole and Its Alternative Clinical CYP3A4/5 Inhibitors as Inhibitors of Drug Transporters: The In Vitro Effects of Ketoconazole, Ritonavir, Clarithromycin, and Itraconazole on 13 Clinically-Relevant Drug Transporters
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Effect of Clinical CYP3A4/5 Inhibitors on Drug Transporters

Lydia M. M. Vermeer, Caleb D. Isringhausen, Brian W. Ogilvie and David B. Buckley
Drug Metabolism and Disposition March 1, 2016, 44 (3) 453-459; DOI: https://doi.org/10.1124/dmd.115.067744

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Effect of Clinical CYP3A4/5 Inhibitors on Drug Transporters

Lydia M. M. Vermeer, Caleb D. Isringhausen, Brian W. Ogilvie and David B. Buckley
Drug Metabolism and Disposition March 1, 2016, 44 (3) 453-459; DOI: https://doi.org/10.1124/dmd.115.067744
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • Mass Balance Recovery and Disposition of AZD4831 in Humans
  • Biotransformation of AZD4831 in Animals and Humans
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics